PB2389 UNDERDOSING DEFERIPRONE IN TM: MYTH OR REALITY?
نویسندگان
چکیده
منابع مشابه
Mesopancreas: myth or reality?
CONTEXT A recently published study hypothesized the concept of 'mesopancreas', defining it as a firm, well-vascularized structure extending from the posterior surface of the pancreatic head to behind the mesenteric vessels. OBJECTIVE To verify and define mesopancreas from resection specimens obtained from fresh cadavers. DESIGN Postmortem anatomical-pathological study. SETTING Department ...
متن کاملMyth or Reality?
Received July 17, 2012; final revision received September 26, 2012; accepted September 27, 2012. From the Unité Neuro-Vasculaire, Hôpitaux Universitaires de Strasbourg, Strasbourg Cedex, France (V.W.,V.L.,O.R.,M.B.,C.M.); Université de Strasbourg, EA 3072, Faculté de Médecine, Strasbourg Cedex, France (V.W.,O.R.,B.G.); and Université de Strasbourg, CNRS UMR-7237, Faculté de Médecine, Strasbourg...
متن کاملGlobal bioethics – myth or reality?
BACKGROUND There has been debate on whether a global or unified field of bioethics exists. If bioethics is a unified global field, or at the very least a closely shared way of thinking, then we should expect bioethicists to behave the same way in their academic activities anywhere in the world. This paper investigates whether there is a 'global bioethics' in the sense of a unified academic comm...
متن کاملMyth or Reality—Transdermal Magnesium?
In the following review, we evaluated the current literature and evidence-based data on transdermal magnesium application and show that the propagation of transdermal magnesium is scientifically unsupported. The importance of magnesium and the positive effects of magnesium supplementation are extensively documented in magnesium deficiency, e.g., cardiovascular disease and diabetes mellitus. The...
متن کاملTransplantation tolerance; myth or reality?
Implication for health policy/practice/research/medical education: Transplantation is now a well-accepted therapy for end organ failure. However the recipients are required to take life-long immunosuppression to prevent rejection. This leads to immunosuppression associated morbidity in the form of viral/ fungal/ bacterial infections in addition to causing financial burden on the system. Over a ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: HemaSphere
سال: 2019
ISSN: 2572-9241
DOI: 10.1097/01.hs9.0000568020.57335.3b